Stuart C. Apfel
7Patents
7h-index
4Co-inventors
45Inventor score
Filing activity: Apr 16, 1993 → Dec 17, 1996
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585348A | Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia | Emerging Cross-Sectional Technologies | 115 | Expired |
| US5648335A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 106 | Expired |
| US5569648A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 74 | Expired |
| US5420112A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5633228A | Prevention and treatment of peripheral neuropathy | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5604202A | Use of NGF growth factors to treat drug-induced neuropathy | Human Necessities | 27 | Expired |
| US6011004A | Use of growth factors to treat drug-inducted neuropathy | Human Necessities | 26 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.